CGPCS
BHVN

Capital Group Private Client Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Capital Group Private Client Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-68,570
Closed -$10.4M – 252
2022
Q3 		$10.4M Buy
68,570
+332
+0.5% +$49.2K 0.15% 128
2022
Q2 		$9.94M Sell
68,238
-323
-0.5% -$41.3K 0.13% 137
2022
Q1 		$8.13M Buy
68,561
+1,222
+2% +$152K 0.09% 148
2021
Q4 		$9.28M Sell
67,339
-1,012
-1% -$129K 0.1% 135
2021
Q3 		$9.49M Buy
+68,351
New +$8.53M 0.11% 131

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Capital Group Private Client Services's BHVN Position: Q4 2022 in Review

Capital Group Private Client Services sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 68,570 shares — an estimated $10.4M sold.

Capital Group Private Client Services first reported a position in BHVN in Q3 2021 and held it in 5 quarters. The position peaked at $10.4M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Capital Group Private Client Services reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Capital Group Private Client Services sold 68,570 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $10.4M.
  • Capital Group Private Client Services first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2021 and held it in 5 quarters.
  • Capital Group Private Client Services's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10.4M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Capital Group Private Client Services's 13F filing for Q4 2022, filed 14 Feb 2023.